✦ LIBER ✦

Pathways into ecstasy use: The role of prior cannabis use and ecstasy availability

✍ Scribed by Petra Zimmermann; Hans-Ulrich Wittchen; Florian Waszak; Agnes Nocon; Michael Höfler; Roselind Lieb

Book ID: 116411373
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 147 KB
Volume: 79
Category: Article
ISSN: 0376-8716
DOI: 10.1016/j.drugalcdep.2005.02.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.6.c.007 Pathways into ecstasy use: the

P.6.c.007 Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability

✍ H.U. Wittchen; P. Zimmermann; F. Waszak; A. Nocon; M. Hoefler; R. Lieb 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Ecstasy and Gateway Drugs: Initiating th

Ecstasy and Gateway Drugs: Initiating the Use of Ecstasy and Other Drugs

✍ Lesley W. Reid; Kirk W. Elifson; Claire E. Sterk 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 145 KB

The effects of concurrent cannabis use a

The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?

✍ John E. Fisk; Catharine Montgomery; Michelle Wareing; Philip N. Murphy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract The research evidence regarding the potential effects of ecstasy suggests that it may be neurotoxic and that its use is associated with cognitive impairment. In recent years evidence has emerged suggesting that cannabinoids, the active ingredients in cannabis, can be neuroprotective und

Ecstasy and the concomitant use of pharm

Ecstasy and the concomitant use of pharmaceuticals

✍ Jan Copeland; Paul Dillon; Michael Gascoigne 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Pattern of cannabis use in ecstasy polyd

Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms

✍ R. M. Milani; A. C. Parrott; F. Schifano; J. J. D. Turner 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

## Abstract Cannabis is one of the most common ‚co‐drugs’︁ for ecstasy users. The aim of the present study was to explore self‐reported psychobiological problems in ecstasy polydrug users in relation to their pattern of cannabis use. Two hundred and eighty ecstasy polydrug users were allocated into

Psychological profile of abstinent recre

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use

✍ Joerg Daumann; Susanna Pelz; Stefanie Becker; Frank Tuchtenhagen; Euphrosyne Gou 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The popular recreational drug Ecstasy (3,4-methylenedioxymethamphetamine, or MDMA, and related congeners) is neurotoxic upon central serotonergic systems in animal studies. So far, the most convincing evidence for neurotoxicity-related functional deficits in humans derives from neurocognitive studie